Search - tctmd.com

Displaying 861 - 880 of 1134

Sort: Relevancy | Date

Presentation TVT 2016

Will Surgical or Transcatheter Neochordal Repair Become an Important Alternative?

Presenter: Michael A. Borger

June 16, 2016

Presentation TVT 2016

Surgical Mitral Repair State-of-the Art 2016?

Presenter: Steven F. Bolling

June 16, 2016

Presentation TVT 2016

Mitral Bioskills

Presenter: Mark Reisman

June 16, 2016

Presentation TVT 2016

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

Presentation TVT 2016

The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes

Presenter: Vasilis Babaliaros

June 16, 2016

Presentation TVT 2016

TAVR Bioskills

Presenter: Mark Reisman

June 16, 2016

Presentation TVT 2016

Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Presenter: Martin B. Leon

June 16, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Industry News

Tips for Convincing Your Boss to Attend TCT 2016

April 13, 2016

News Daily News

Study Fails to Support Routine PCI for Older Patients With Syncope and CAD

L.A. McKeown

March 07, 2016

News Conference News CRT 2016

Health Apps, Bar Codes, and Big Data: The “Brave New World” of Medical Device Innovation

Shelley Wood

February 23, 2016

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

News Daily News

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

L.A. McKeown

November 17, 2015

News Industry News

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

October 16, 2015

Presentation TCT 2015

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Martin W Bergmann

October 15, 2015

Presentation TCT 2015

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Brij Maini

October 15, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Alec S. Vahanian

October 15, 2015

Advertisement

Will Surgical or Transcatheter Neochordal Repair Become an Important Alternative?

Surgical Mitral Repair State-of-the Art 2016?

Mitral Bioskills

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

The Case for and Against Cerebral Embolic Protection During TAVR

The Minimalist TAVR Credo: Keep It Simple! Impact on Clinical Pathway Efficiencies and Outcomes

TAVR Bioskills

Appropriate Use of TAVR Now and in the Future: A Surgeons Perspective

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Tips for Convincing Your Boss to Attend TCT 2016

Study Fails to Support Routine PCI for Older Patients With Syncope and CAD

Health Apps, Bar Codes, and Big Data: The “Brave New World” of Medical Device Innovation

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

Experts Debate Merits of Guideline-Directed Care for Patients With Multivessel Disease

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding Focused Commentary

LAA Closure vs Pharmacotherapy (Including NOACs) in a Patient With AF and Intermediate Risk of Bleeding

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content